KAINOS Laboratories,Inc. 4556Short Interest
No institution currently reports a short position of 0.5% or more in KAINOS Laboratories,Inc. (4556). The last disclosure was on 2023-02-21 (Nomura International plc, 0.37%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
232 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 6 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2020-01-28 |
|---|---|
| Latest disclosure | 2023-02-21 (Nomura International plc, 0.37%) |
| Reporting institutions | 6 firms (232 reports) |
| Peak estimated short interest | 3.42% (2020-02-10, 3 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 2 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- MERRILL LYNCH INTERNATIONAL
- Nomura International plc
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2021-10-07 | JPM Securities Japan Co Ltd. | Position 22,700 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2021-11-19 | Credit Suisse AG | Position 22,500 shares | Ratio 0.49% | ▼0.09% | Below 0.5% |
| 2022-04-28 | MERRILL LYNCH INTERNATIONAL | Position 22,100 shares | Ratio 0.48% | ▼0.03% | Below 0.5% |
| 2020-02-18 | UBS AG | Position 20,800 shares | Ratio 0.45% | ▼0.13% | Below 0.5% |
| 2020-08-26 | Morgan Stanley MUFG Securities Co., Ltd. | Position 19,800 shares | Ratio 0.43% | ▼0.14% | Below 0.5% |
| 2023-02-21 | Nomura International plc | Position 17,200 shares | Ratio 0.37% | ▼0.19% | Below 0.5% |
Disclosure History 232 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2023-02-21 | Nomura International plc | Position 17,200 shares | Ratio 0.37% | ▼0.19% | Below 0.5% |
| 2023-02-15 | Nomura International plc | Position 25,600 shares | Ratio 0.56% | ▼0.11% | — |
| 2023-02-09 | Nomura International plc | Position 30,600 shares | Ratio 0.67% | ▼0.12% | — |
| 2023-02-07 | Nomura International plc | Position 36,100 shares | Ratio 0.79% | ▼0.10% | — |
| 2023-02-02 | Nomura International plc | Position 40,700 shares | Ratio 0.89% | ▼0.07% | — |
| 2023-01-26 | Nomura International plc | Position 44,000 shares | Ratio 0.96% | ▼0.09% | — |
| 2023-01-25 | Nomura International plc | Position 48,300 shares | Ratio 1.05% | ▲0.77% | — |
| 2022-10-28 | Nomura International plc | Position 15,300 shares | Ratio 0.33% | ▼0.19% | Below 0.5% |
| 2022-10-27 | Nomura International plc | Position 24,000 shares | Ratio 0.52% | ▼0.10% | — |
| 2022-10-25 | Nomura International plc | Position 28,500 shares | Ratio 0.62% | ▲0.06% | — |
| 2022-10-21 | Nomura International plc | Position 25,700 shares | Ratio 0.56% | ▼0.13% | — |
| 2022-10-18 | Nomura International plc | Position 31,500 shares | Ratio 0.69% | ▼0.02% | — |
| 2022-10-14 | Nomura International plc | Position 32,400 shares | Ratio 0.71% | ▲0.12% | — |
| 2022-10-13 | Nomura International plc | Position 27,000 shares | Ratio 0.59% | ▲0.42% | — |
| 2022-04-28 | MERRILL LYNCH INTERNATIONAL | Position 22,100 shares | Ratio 0.48% | ▼0.03% | Below 0.5% |
| 2022-04-27 | MERRILL LYNCH INTERNATIONAL | Position 23,500 shares | Ratio 0.51% | ▼0.01% | — |
| 2022-04-26 | MERRILL LYNCH INTERNATIONAL | Position 23,800 shares | Ratio 0.52% | ▼0.01% | — |
| 2022-04-25 | MERRILL LYNCH INTERNATIONAL | Position 24,200 shares | Ratio 0.53% | ▲0.03% | — |
| 2022-04-22 | MERRILL LYNCH INTERNATIONAL | Position 22,800 shares | Ratio 0.50% | ▲0.01% | — |
| 2022-04-21 | MERRILL LYNCH INTERNATIONAL | Position 22,600 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2022-04-20 | MERRILL LYNCH INTERNATIONAL | Position 23,300 shares | Ratio 0.51% | ▼0.01% | — |
| 2022-04-19 | MERRILL LYNCH INTERNATIONAL | Position 23,800 shares | Ratio 0.52% | ▲0.01% | — |
| 2022-04-18 | MERRILL LYNCH INTERNATIONAL | Position 23,700 shares | Ratio 0.51% | ▼0.01% | — |
| 2022-04-14 | MERRILL LYNCH INTERNATIONAL | Position 23,900 shares | Ratio 0.52% | ▼0.03% | — |
| 2022-04-13 | MERRILL LYNCH INTERNATIONAL | Position 25,400 shares | Ratio 0.55% | ▼0.03% | — |
| 2022-04-12 | MERRILL LYNCH INTERNATIONAL | Position 26,800 shares | Ratio 0.58% | ▼0.01% | — |
| 2022-04-11 | MERRILL LYNCH INTERNATIONAL | Position 27,300 shares | Ratio 0.59% | ▼0.03% | — |
| 2022-04-08 | MERRILL LYNCH INTERNATIONAL | Position 28,700 shares | Ratio 0.62% | ▼0.03% | — |
| 2022-04-07 | MERRILL LYNCH INTERNATIONAL | Position 29,700 shares | Ratio 0.65% | ▼0.06% | — |
| 2022-04-06 | MERRILL LYNCH INTERNATIONAL | Position 32,600 shares | Ratio 0.71% | ▼0.01% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| SEIKAGAKU CORPORATION4548 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| EIKEN CHEMICAL CO.,LTD.4549 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| JCR Pharmaceuticals Co.,Ltd.4552 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| TOWA PHARMACEUTICAL CO.,LTD.4553 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| Fuji Pharma Co.,Ltd.4554 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| CHUKYO IYAKUHIN CO.,LTD.4558 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| ZERIA PHARMACEUTICAL CO.,LTD.4559 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| AnGes,Inc.4563 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| OncoTherapy Science,Inc.4564 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Nxera Pharma Co.,Ltd.4565 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |